UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $1.45M invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
3
Calls
$289K
Puts
–
Net Calls
+$289K
Net Calls Change
+$57K
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$391K |
2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$343K |
3 |
UBS Group
Zurich,
Switzerland
|
+$57K |
Top Sellers
1 |
VF
Virtu Financial
New York
|
-$244K |
2 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$209K |
3 |
Jane Street
New York
|
-$198K |
4 |
![]()
Simplex Trading
Chicago,
Illinois
|
-$9K |